HHS Watchdog To Probe Enforcement Of Nursing Home Staffing Standards

The study follows a Kaiser Health News and New York Times investigation that found nearly 1,400 nursing homes have reported fewer registered nurses on duty than Medicare requires or failed to provide reliable staffing information to the government.

The Pluses And Minuses Of Allowing Medical Marijuana At School

As more parents turn to medical marijuana to treat their sick children, a handful of states have changed the rules to allow them to administer the drug on campus. California is considering it — at the possible risk of losing federal funding.

Californians Living Longer With Cancer — Some Longer Than Others

A new study from the University of California-Davis shows a significant increase in five-year survival rates for more than 20 types of cancer, but with significant disparities by race, ethnicity and economic status. That is in line with the national trend.

Podcast: KHN’s ‘What The Health?’ Opioids, EpiPens And Health Funding

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?

Religious Conservatives’ Ties To Trump Officials Pay Off In AIDS Policies, Funding

Shepherd Smith, a strong supporter of abstinence-only sex education for AIDS, has been close to the new director of the CDC for decades. This connection is just one example of the “new in crowd” surrounding the Trump administration, where politics and religion mix.

Rehabilitation Plus Rehab? Jails Dispense Drugs To Treat Inmates’ Addictions

Rather than go cold turkey, inmates increasingly have the option to take medication to help beat addiction to opioids and other substances. But some warn these substitute drugs serve as another crutch — and a costly one at that.

The Man Who Sold America On Vitamin D — And Profited In The Process

The doctor most responsible for turning the sunshine supplement into a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry, according to government records and interviews.